Cell loss the same with standard phaco and MICS

Article

Phacoemulsification performed with a standard technique yields no significant differences in endothelial cell loss or endothelial morphology when compared with the procedure performed by bimanual microincision cataract surgery (MICS), according to the results of a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Phacoemulsification performed with a standard technique yields no significant differences in endothelial cell loss or endothelial morphology when compared with the procedure performed by bimanual microincision cataract surgery (MICS), according to the results of a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Rita Mencucci, MD and co-workers from the Department of Oto-Neuro-Ophthalmological Surgical Sciences Eye Clinic, University of Florence, Florence, Italy, randomized 80 patients into two groups; 40 eyes to undergo standard stop and chop phaco and the other 40 eyes to receive stop and chop phaco with bimanual MICS. Corneal endothelial cell counts, coefficient of variation in cell size, hexagonality and pachymetry were assessed preoperatively and then again one and three months postoperatively.

Preoperatively, the mean cell count for the entire sample was 2,245 cells/mm² ± 37 (SE). The mean count decreased by 102 cells at one month and by 144 at three months. The difference between the standard group and the MICS group was 25 cells at baseline, 19 cells at one month and 19 cells at three months. There were no changes in the coefficient of variation or morphology in the overall sample and the pattern of change did not differ between the two groups. Corneal thickness increased by 10.2 µm in the overall sample and approached baseline values by three months with an increase of 3.4 µm. There was no difference in corneal thickness between the two groups.

The authors concluded that no significant differences could be found in corneal endothelial cell loss or endothelial morphology between the two techniques.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.